VALHALLA, N.Y. – The U.S. Department of Health and Human Services has provided New York Medical College with a $571,274 federal grant to fund the research of chemotherapy’s damaging effects on ovaries during cancer treatment.
The research project, led by Dr. Kutluk Oktay, will seek to reveal the mechanisms of chemotherapy-induced ovarian hazards as well as to develop medical treatments that prevent such harm and preserve fertility. Such treatments may reduce the need for expensive and invasive assisted-reproduction techniques after chemotherapy.
“By understanding how chemotherapy damages ovaries, medical treatments can be developed to preserve fertility during cancer treatments,” said Oktay.
According to the college, between two and nine percent of children and reproductive-aged people will be exposed to the fertility-damaging side effects of cancer treatment. While various fertility preservation methods have been developed, medical professionals still don’t fully understand how chemotherapy damages ovaries.
“These federal investments could help put an end to the cycle of suffering caused by cancer,” said U.S. Rep. Nita M. Lowey (D-Westchester/Rockland). “I’m immensely proud of the Lower Hudson Valley’s medical research sector, which is hard at work improving the quality of life for people suffering from debilitating diseases, while growing our regional economy. As ranking member of the House Appropriations Committee, I will continue to fight for increased medical research funding that helps women and children overcome cancer.” Lowey is a member of the subcommittee that funds medical research.